Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
105,337,747
-
Number of holders
-
171
-
Total 13F shares, excl. options
-
111,964,031
-
Shares change
-
-6,779,934
-
Total reported value, excl. options
-
$1,816,272,346
-
Value change
-
-$102,065,530
-
Put/Call ratio
-
53%
-
Number of buys
-
74
-
Number of sells
-
-85
-
Price
-
$16.22
Significant Holders of Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX) as of Q3 2025
203 filings reported holding EWTX - Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2025.
Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX) has 171 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 111,964,031 shares
.
Largest 10 shareholders include ORBIMED ADVISORS LLC (15,518,492 shares), RA CAPITAL MANAGEMENT, L.P. (10,428,437 shares), BAKER BROS. ADVISORS LP (7,305,940 shares), BlackRock, Inc. (6,351,487 shares), Paradigm Biocapital Advisors LP (6,170,131 shares), NOVO HOLDINGS A/S (5,350,000 shares), BRAIDWELL LP (5,210,831 shares), JANUS HENDERSON GROUP PLC (4,979,331 shares), VANGUARD GROUP INC (4,803,941 shares), and Cormorant Asset Management, LP (4,010,000 shares).
This table shows the top 171 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.